Rafael Holdings, Inc. SEC filings RFL

Rafael Holdings, Inc. has 409 filings in SEC EDGAR's recent list, going back to Oct 31, 2017. Its latest annual report, Form 10-K, was filed on Oct 29, 2026 for the period ended Jul 31, 2026. The latest quarterly report (Form 10-Q) was filed on Jun 11, 2026, covering the quarter ended Apr 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations, regulation fd disclosure, other events). The company's fiscal year ends on July 31.

Rafael Holdings, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Jan 27, 2026 —
S-8 Employee stock plan registration Jun 26, 2025 —
424B3 Prospectus May 6, 2025 —
S-3/A Amendment no. 1 to form s-3 Apr 28, 2025 —
S-3 Shelf registration Apr 18, 2025 —
424B3 Prospectus Feb 13, 2025 —
S-4/A Registration statement Feb 13, 2025 —
S-4/A Registration statement Feb 11, 2025 —
S-4/A Registration statement Jan 10, 2025 —
S-4/A Registration statement Dec 20, 2024 —
S-4/A Registration statement Nov 22, 2024 —
S-4 Registration for a merger or exchange Oct 9, 2024 —
S-8 Employee stock plan registration Aug 29, 2023 —
S-3/A Amendment no. 1 to form s-3 Mar 2, 2022 —
S-3 Shelf registration Feb 15, 2022 —
S-8 Employee stock plan registration Jan 19, 2022 —
S-4 Registration for a merger or exchange Sep 14, 2021 —
S-3 Shelf registration Jun 7, 2021 —
S-3 Shelf registration May 27, 2021 —
S-8 Employee stock plan registration May 26, 2021 —
S-8 Employee stock plan registration Apr 14, 2021 —
S-3/A Pre-effective amendment no.1 to form s-3 Mar 11, 2021 —
S-3 Shelf registration Feb 24, 2021 —
S-3 Shelf registration Jan 20, 2021 —
S-8 Employee stock plan registration May 22, 2018 —

Showing 25 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
RFL (NYSE)
Fiscal year ends
July 31
Incorporated in
DE
Headquarters
Newark, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1713863

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.